BeijingA 1.29 million yuan CAR-T therapy now costs 288,600 yuan.
China’s insurer added 107 drugs, a record 51 of them class-1 innovations.
Basic insurance covers essentials while a commercial list of 28 drugs carries costlier therapies, including 7 CAR-T products.
Only adults who failed second-line therapy qualify, and patients’ share is estimated at under 100,000 yuan.
The list takes effect 1 January 2027, and regulators will track real-world haemophilia drug use before renewal.
How each outlet framed it
- TMTPost
- reads the new catalog as a shift from price cuts to value selection, with a two-tier 'basic insurance, commercial top-up' payment system
Sources: TMTPost